‌

US Patent 11834654 Antigen binding molecules and methods of use thereof

Patent 11834654 was granted and assigned to Kite Pharma, Inc. on December, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Kite Pharma, Inc.

0

Current Assignee

Kite Pharma, Inc.

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jed J. W. Wiltzius0

Stuart A. Sievers0

Date of Patent

December 5, 2023

0

Patent Application Number

170944580

Date Filed

November 10, 2020

0

Patent Citations

US Patent 8957193 Polynucleotides encoding anti-CD40 antibodies

0

US Patent 6881557 Super humanized antibodies

0

US Patent 7709226 Method of humanizing antibodies by matching canonical structure types CDRs

0

US Patent 10844371 Antigen binding molecules and methods of use thereof

0

Patent Primary Examiner

0

Patent abstract

Isolated antigen binding molecules that specifically binds to a molecule comprising an amino acid sequence selected from the group consisting of GGGS (SEQ ID NO: 1), GGGGS (SEQ ID NO: 46) and related sequences are provided. The antigen binding molecules may be used in the methods provided herein.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11834654 Antigen binding molecules and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool